Cite
Application of CRISPR/Cas9-based mutant enrichment technique to improve the clinical sensitivity of plasma EGFR testing in patients with non-small cell lung cancer.
MLA
Kim, Boyeon, et al. “Application of CRISPR/Cas9-Based Mutant Enrichment Technique to Improve the Clinical Sensitivity of Plasma EGFR Testing in Patients with Non-Small Cell Lung Cancer.” Cancer Cell International, vol. 22, no. 1, Feb. 2022, pp. 1–11. EBSCOhost, https://doi.org/10.1186/s12935-022-02504-2.
APA
Kim, B., Kim, Y., Shin, S., Lee, S.-T., Cho, J. Y., & Lee, K.-A. (2022). Application of CRISPR/Cas9-based mutant enrichment technique to improve the clinical sensitivity of plasma EGFR testing in patients with non-small cell lung cancer. Cancer Cell International, 22(1), 1–11. https://doi.org/10.1186/s12935-022-02504-2
Chicago
Kim, Boyeon, Yoonjung Kim, Saeam Shin, Seung-Tae Lee, Jae Yong Cho, and Kyung-A. Lee. 2022. “Application of CRISPR/Cas9-Based Mutant Enrichment Technique to Improve the Clinical Sensitivity of Plasma EGFR Testing in Patients with Non-Small Cell Lung Cancer.” Cancer Cell International 22 (1): 1–11. doi:10.1186/s12935-022-02504-2.